Symbols

VVOS

Vivos·NASDAQ

--(--)

VVOS fundamentals

VVOS Q2 2025 Earnings

Vivos (VVOS) released its earnings on Aug 19, 2025: revenue was 3.82M (YoY -5.77%), beat estimates; EPS was -0.55 (YoY +8.33%), missed estimates.

Revenue / YoY

3.82M

-5.77%

EPS / YoY

-0.55

+8.33%

Report date

Aug 19, 2025

VVOS Earnings Call Summary for Q2,2025

Strategic Pivot Success: SCN acquisition generated $500k revenue in 20 days, with 1.5 SO teams processing 250 patients/month.
Financial Transition: Q2 operating loss of $4.9M driven by $1.8M one-time costs, but $11.5M financing provides liquidity.
Growth Catalysts: Targeting 8 SO teams by 2026, with Michigan expansion under new collaboration model.
Cash Flow Target: Aiming for Q4 2025 cash flow breakeven as SO teams scale.

Earnings

EPS

Revenue

Revenue & Expenses

VVOS has released its 2025 Q3 earnings report, with revenue of 6.78M, reflecting a YoY change of 75.73%, and net profit of -5.40M, showing a YoY change of -106.42%. The Sankey diagram below clearly presents VVOS's revenue sources and cost distribution.

Key Indicators

Vivos (VVOS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Vivos (VVOS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Vivos (VVOS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Vivos (VVOS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown